Advances in Acne Management: From Empiricism to Evidence-Based Care

Authors

  • Megan MacArthur UCC Dermatology Society
  • Nora Skuridina
  • Alison Martin
  • Araz Derohan
  • Hiva Fazeli
  • Andrew Sharobim
  • Kashaf Qureshi
  • Andrew O’Brien
  • Conor McQuillan
  • Jeongmin Lim
  • Neelab Ibrahimi

DOI:

https://doi.org/10.33178/SMJ.2026.5

Keywords:

Acne vulgaris, Dermatology history, Antibiotic stewardship, Retinoids and isotretinoin, Multimodal acne management, Hormonal therapy, Precision dermatology

Abstract

Acne vulgaris is a chronic inflammatory disorder with significant psychosocial impact. Its prevalence and prolonged disease course make it an ideal condition for examining the historical evolution of dermatology from empiricism to evidence-based, mechanism-driven care. Early explanations of acne were grounded in pre-scientific medical paradigms, in which the classical humoral theory attributed cutaneous disease to internal imbalance, diet, hygiene, and environmental impurities. The mid-twentieth century was marked by advances in microbiology and pharmacology, facilitating the development of targeted therapies, including antibiotics, retinoids, and isotretinoin, thereby transforming acne treatment into pathophysiology-driven care. By the late twentieth century, the role of hormonal regulation became increasingly apparent, with androgens being recognised as key drivers of acne pathogenesis. Concurrently, growing recognition of the psychological burden of acne contributed to the emergence of psychodermatology. Modern acne management is characterised by an evidence-based, multimodal approach that reflects the disease’s multifactorial pathogenesis, with combination therapy now considered standard of care. Emerging therapies and digital innovations highlight an ongoing shift towards precision and sustainability. 

 

References

1. Tan J, et al. Global burden and epidemiology of acne vulgaris. J Am Acad Dermatol. 2023. Available from: https://www.jaad.org/article/S0190-9622(23)03389-3/fulltext

2. Vos T, et al. Global prevalence and burden of acne vulgaris. Lancet. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/40996945/

3. Dalgard FJ, et al. The psychological burden of skin diseases: acne and quality of life. Br J Dermatol. 2008. Available from: https://pubmed.ncbi.nlm.nih.gov/20844551/

4. Eber, A.E., Perper, M., Magno, R. and Nouri, K. (2017), Acne treatment in antiquity: can approaches from the past be relevant in the future? Int J Dermatol, 56: 1071-1073. https://doi.org/10.1111/ijd.13741

5. Plewig G, Kligman AM. Historical perspectives on acne pathogenesis and treatment. Dermatol Clin. 2025. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0738081X25002949

6. Ribero S, et al. Sebaceous gland biology and acne. J Eur Acad Dermatol Venereol. 2023. Available from: https://www.sciencedirect.com/science/article/pii/S2405580823001590

7. Williams HC, et al. Antibiotics for acne vulgaris: efficacy and mechanisms. BMJ. 2009. Available from: https://pubmed.ncbi.nlm.nih.gov/19125773/

8. Dréno B, et al. Antibiotic resistance in acne: global implications. J Eur Acad Dermatol Venereol. 2016. Available from: https://pubmed.ncbi.nlm.nih.gov/27330299/

9. Kligman AM. The role of retinoids in acne therapy. Arch Dermatol. 1969. Available from: https://pubmed.ncbi.nlm.nih.gov/14119102/

10. Peck GL, et al. Prolonged remission of acne with isotretinoin. N Engl J Med. 1979. Available from: https://pubmed.ncbi.nlm.nih.gov/443246/

11. Layton AM. Safety and regulatory considerations of isotretinoin. Br J Dermatol. 2005. Available from: https://pubmed.ncbi.nlm.nih.gov/16225670/

12. Lai J, Barbieri JS. Acne relapse and isotretinoin retrial in patients with acne. JAMA Dermatology. 2025. doi:10.1001/jamadermatol.2024.5416.

13. Tan JKL, et al. Adherence and patient-centred outcomes in acne management. J Am Acad Dermatol. 2015. Available from: https://www.jaad.org/article/S0190-9622(15)02614-6/fulltext

14. Zouboulis CC. Endocrinology of the sebaceous gland and acne. J Invest Dermatol. 2015. Available from: https://www.sciencedirect.com/science/article/pii/S0022202X15497313

15. Thiboutot D, et al. Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris. Lancet. 2016. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5015761/

16. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clinical and Experimental Dermatology. 1994;19(3):210–216. Available from: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x

17. Vyas J, Johns JR, Abdelrazik Y, Ali FM, Ingram JR, Salek S, et al.

The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality-of-life instruments: A systematic review. Journal of the European Academy of Dermatology and Venereology. 2025;39:631–679. Available from: https://doi.org/10.1111/jdv.20321

18. Nast A, Al Wattar BH, Beylot Barry M, et al. Update of the EuroGuiDerm evidence-based guideline for the treatment of acne—Short version. J Eur Acad Dermatol Venereol. 2026. doi:10.1111/jdv.70331.

19. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006.e1–1006.e30. doi:10.1016/j.jaad.2023.12.017.

20. Health Service Executive (HSE). Acne vulgaris – antibiotic prescribing guidelines. 2023. Available from: https://www.hse.ie/eng/services/list/2/gp/antibiotic-prescribing/conditions-and-treatments/skin-soft-tissue/acne-vulgaris/

21. Baldwin H, et al. Antibiotic stewardship in acne: 2023 update. J Drugs Dermatol. 2023. Available from: https://jddonline.com/articles/individual-article-antibiotic-stewardship-in-acne-2023-update-s1545961624ssf37896s4x/

22. Thiboutot DM, et al. New insights into the management of acne. J Am Acad Dermatol. 2003. Available from: https://www.sciencedirect.com/science/article/pii/S019096220301154X

23. Pires L, González-Paramás AM, Heleno SA, Calhelha RC. Exploring therapeutic advances: a comprehensive review of intestinal microbiota modulators. Antibiotics. 2024.

24. Łuczak JW, Palusińska M, Maślińska-Gromadka K, Pietrzak D, Szopiński T, Lewicki S, et al. Novel anti-inflammatory approaches in dermatology. Int J Mol Sci. 2023.

25. Traini DO, Palmisano G, Guerriero C, Peris K. Artificial intelligence in the assessment and grading of acne vulgaris: a systematic review. J Pers Med. 2025. Available from: https://pubmed.ncbi.nlm.nih.gov/40559101/

Published

2026-10-22

Issue

Section

Special Feature

Categories

How to Cite

Advances in Acne Management: From Empiricism to Evidence-Based Care. (2026). UCC Student Medical Journal, 6. https://doi.org/10.33178/SMJ.2026.5